Zheng Ping

Dr. Zheng Ping is a scientist and director of operations at Clover Biopharmaceuticals. Zheng has over 10 years of experience in the pharmaceutical industry, having worked previously as a postdoctoral researcher at Cleveland Clinic and as a scientist at Bristol Myers Squibb. Dr. Zheng has a passion for drug development and has played a key role in several major projects at Clover, including the development of a new treatment for patients with autoimmune diseases. Zheng is also a board member of the company. Dr. Zheng received their PhD in medicinal chemistry from the University of Michigan.

Zheng Ping received their Doctor of Philosophy in Pharmaceutical Sciences from Peking Union Medical College and their Doctor of Medicine in clinical medicine from Weifang Medical College. They also have certification from NIH Office of clinical research in Introduction to the principles and practice of clinical research, Principles of clinical pharmacology, and NIDA clinical trial network in Good Clinical Practice.

Some of their coworkers include Qi Liang - SVP, Antibody Discovery, Cindy Min - SVP, Public Affairs, and Aileen Wang - Chief Financial Officer. Zheng Ping reports to Peng Liang, Co-Founder, President & Chairman.